Bioavailability of seocalcitol I:: Relating solubility in biorelevant media with oral bioavailability in rats -: Effect of medium and long chain triglycerides

被引:46
作者
Grove, M
Pedersen, GP
Nielsen, JL
Müllertz, A
机构
[1] LEO Pharma AS, Pharmaceut Fdn, DK-2750 Ballerup, Denmark
[2] LEO Pharma AS, Dept Pharmacokinet, DK-2750 Ballerup, Denmark
[3] Danish Univ Pharmaceut Sci, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
关键词
oral bioavailability; lipid-based formulations; oral absorption; poorly soluble drug substances; solubility; simulated intestinal media; seocalcitol;
D O I
10.1002/jps.20403
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Simulated intestinal media (SIM) containing bile salt (BS) and phospholipids (PL) with and without medium chain lipolytic products (MC-LP) or long chain lipolytic products (LC-LP) were developed to study the solubility of seocalcitol. Both MC-LP and LC-LP were studied in order to investigate the influence of fatty acid chain length on the in vitro solubility of seocalcitol. The same solubility of seocalcitol was found in media containing either MC-LP or LC-LP. The bioavailability after oral administration of seocalcitol dissolved in medium chain triglyceride (MCT), long chain triglyceride (LCT), and a reference formulation containing propylene glycol (PG) was studied in vivo in rats. The lipid formulations showed a twofold increase in bioavailability compared with the reference formulation, indicating positive effects of lipids on the bioavailability reflecting a better solubility in the intestine and protection against precipitation of seocalcitol in the gastro intestinal tract. There was no difference in the in vivo bioavailability of seocalcitol between the MCT and the LCT solutions, which correlates with the identical in vitro solubility of seocalcitol in SIM containing MC-LP or LC-LP. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1830 / 1838
页数:9
相关论文
共 21 条
[1]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]
Comparison of cyclosporin a absorption from LCT and MCT solutions following intrajejunal administration in conscious dogs [J].
Behrens, D ;
Fricker, R ;
Bodoky, A ;
Drewe, J ;
Harder, F ;
Heberer, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :666-668
[3]
Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats [J].
DeSesso, JM ;
Jacobson, CF .
FOOD AND CHEMICAL TOXICOLOGY, 2001, 39 (03) :209-228
[4]
ERHLINGER S, 1987, PHYSL GASTROINTESTIN, P1557
[5]
INVITRO MODEL FOR LIPASE-CATALYZED LIPOPHILE RELEASE FROM FATS [J].
FOUAD, FM ;
FARRELL, PG ;
MARSHALL, WD ;
VANDEVOORT, FR .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1991, 39 (01) :150-153
[6]
GALLOTORRES HE, 1978, INT J VITAM NUTR RES, V48, P240
[7]
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs [J].
Gershanik, T ;
Benita, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :179-188
[8]
ABSORPTION OF A PHARMACOLOGICAL DOSE OF VITAMIN-D3 FROM 2 DIFFERENT LIPID VEHICLES IN MAN - COMPARISON OF PEANUT OIL AND A MEDIUM CHAIN TRIGLYCERIDE [J].
HOLMBERG, I ;
AKSNES, L ;
BERLIN, T ;
LINDBACK, B ;
ZEMGALS, J ;
LINDEKE, B .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1990, 11 (09) :807-815
[9]
Humberstone AJ, 1997, ADV DRUG DELIVER REV, V25, P103, DOI 10.1016/S0169-409X(96)00494-2
[10]
KARARLI TT, 1989, CRIT REV THER DRUG, V6, P39